Sara C. Meyer

1.8k total citations
44 papers, 965 citations indexed

About

Sara C. Meyer is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Sara C. Meyer has authored 44 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 29 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Sara C. Meyer's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (14 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Sara C. Meyer is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (14 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Sara C. Meyer collaborates with scholars based in Switzerland, United States and Austria. Sara C. Meyer's co-authors include Ross L. Levine, Šime Brkić, Johanna A. Kremer Hovinga, Andreas Buser, Jakob Passweg, Radek C. Skoda, Stephan Dirnhofer, Hui Hao-Shen, Simona Stivala and Matthew D. Keller and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Sara C. Meyer

42 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara C. Meyer Switzerland 18 531 437 398 164 156 44 965
Greg Ball United States 13 413 0.8× 306 0.7× 235 0.6× 88 0.5× 121 0.8× 34 861
Pascal Mossuz France 16 499 0.9× 524 1.2× 463 1.2× 214 1.3× 145 0.9× 44 1.0k
Hajnalka Andrikovics Hungary 21 467 0.9× 358 0.8× 463 1.2× 141 0.9× 151 1.0× 90 1.2k
Matteo Molica Italy 16 487 0.9× 341 0.8× 253 0.6× 113 0.7× 82 0.5× 70 773
Lucy J. Elrick United Kingdom 10 587 1.1× 435 1.0× 291 0.7× 278 1.7× 59 0.4× 13 1.1k
Milica C̆olović Serbia 17 468 0.9× 252 0.6× 261 0.7× 59 0.4× 247 1.6× 86 981
Stefan Wilop Germany 21 377 0.7× 188 0.4× 631 1.6× 34 0.2× 89 0.6× 48 1.1k
J A Koedam Netherlands 14 572 1.1× 317 0.7× 219 0.6× 68 0.4× 182 1.2× 19 1.1k
Abelardo Bárez Spain 17 513 1.0× 309 0.7× 386 1.0× 42 0.3× 156 1.0× 42 918
Yi Shan China 14 220 0.4× 112 0.3× 231 0.6× 72 0.4× 81 0.5× 53 708

Countries citing papers authored by Sara C. Meyer

Since Specialization
Citations

This map shows the geographic impact of Sara C. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara C. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara C. Meyer more than expected).

Fields of papers citing papers by Sara C. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara C. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara C. Meyer. The network helps show where Sara C. Meyer may publish in the future.

Co-authorship network of co-authors of Sara C. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Sara C. Meyer. A scholar is included among the top collaborators of Sara C. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara C. Meyer. Sara C. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bacher, Ulrike, Alicia Rovó, Martin Andres, et al.. (2025). Artificial Intelligence in Haematologic Diagnostics: Current Applications and Future Perspectives. Acta Haematologica. 1–14.
2.
Tsakiris, Dimitrios A., et al.. (2024). Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems. Bone Marrow Transplantation. 59(10). 1349–1359. 4 indexed citations
3.
Dunbar, Andrew, Simona Stivala, Šime Brkić, et al.. (2023). Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable. Clinical Cancer Research. 30(3). 586–599. 1 indexed citations
4.
Konantz, Martina, Margaret S. Williams, Stefan Dirnhofer, et al.. (2023). Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis. Journal of Allergy and Clinical Immunology. 152(4). 1019–1024. 5 indexed citations
5.
Medinger, Michael, et al.. (2023). Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes. Frontiers in Oncology. 13. 1205387–1205387. 1 indexed citations
6.
Konantz, Martina, et al.. (2022). Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis. The Journal of Allergy and Clinical Immunology In Practice. 10(11). 3035–3038.e1.
7.
Parmigiani, Elena, Robert Ivánek, Chiara Rolando, et al.. (2022). Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells. Developmental Cell. 57(15). 1847–1865.e9. 26 indexed citations
8.
Brkić, Šime, Simona Stivala, Jakob Passweg, et al.. (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia. 35(10). 2875–2884. 21 indexed citations
9.
Meyer, Sara C., et al.. (2021). Genetics of Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America. 35(2). 217–236. 14 indexed citations
10.
Brkić, Šime & Sara C. Meyer. (2020). Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms. HemaSphere. 5(1). e516–e516. 26 indexed citations
11.
Meyer, Sara C., Simona Stivala, Anne Baerenwaldt, et al.. (2017). Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms. Bern Open Repository and Information System (University of Bern). 4 indexed citations
12.
Meyer, Sara C.. (2017). Mechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America. 31(4). 627–642. 33 indexed citations
13.
Kunimoto, Hiroyoshi, Cem Meydan, Abbas Nazir, et al.. (2017). Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell. 33(1). 44–59.e8. 62 indexed citations
14.
Stivala, Simona, Laura Infanti, Martin F. Reiner, et al.. (2017). Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica. 102(10). 1650–1660. 43 indexed citations
15.
Shimizu, Takafumi, Lucia Kubovčáková, Ronny Nienhold, et al.. (2016). Loss of Ezh2 synergizes with JAK2 -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. The Journal of Experimental Medicine. 213(8). 1479–1496. 82 indexed citations
16.
Meyer, Sara C. & Ross L. Levine. (2014). Translational implications of somatic genomics in acute myeloid leukaemia. The Lancet Oncology. 15(9). e382–e394. 93 indexed citations
17.
Meyer, Sara C., Alix O’Meara, Andreas Buser, et al.. (2012). Prognostic Impact of Posttransplantation Iron Overload after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(3). 440–444. 45 indexed citations
18.
McLennan, Mary T., Jenine K. Harris, Barbara Kariuki, & Sara C. Meyer. (2008). Family history as a risk factor for pelvic organ prolapse. International Urogynecology Journal. 19(8). 1063–1069. 37 indexed citations
19.
Meyer, Sara C., Ramzi Jeddi, Balkis Meddeb, et al.. (2008). A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13. Annals of Hematology. 87(8). 663–666. 22 indexed citations
20.
Meyer, Sara C., et al.. (2005). Severe Valproic Acid Intoxication is Associated with Atrial Tachycardia: Secondary Detoxication by Hemoperfusion. Klinische Pädiatrie. 217(2). 82–85. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greg Ball Breakdown of academic impact, for papers by Pascal Mossuz Breakdown of academic impact, for papers by Hajnalka Andrikovics Breakdown of academic impact, for papers by Matteo Molica Breakdown of academic impact, for papers by Lucy J. Elrick Breakdown of academic impact, for papers by Milica C̆olović Breakdown of academic impact, for papers by Stefan Wilop Breakdown of academic impact, for papers by J A Koedam Breakdown of academic impact, for papers by Abelardo Bárez Breakdown of academic impact, for papers by Yi Shan
Rankless by CCL
2026